Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
MD Anderson announces licensing agreements with BostonGene and Tempus for its EGFR Classification

MD Anderson announces licensing agreements with BostonGene and Tempus for its EGFR Classification

Study finds wide variation in the quality of care for lung cancer across the U.S.

Study finds wide variation in the quality of care for lung cancer across the U.S.

Novel bacterial therapy approach opens up new treatment options for lung cancer patients

Novel bacterial therapy approach opens up new treatment options for lung cancer patients

New imaging agent lights the way for surgeons during lung cancer surgery

New imaging agent lights the way for surgeons during lung cancer surgery

Study suggests new anti-KRAS drug as a strong candidate for pancreatic cancer clinical trials

Study suggests new anti-KRAS drug as a strong candidate for pancreatic cancer clinical trials

Study explores practical pathways to motherhood in women with oncogene-driven lung cancer

Study explores practical pathways to motherhood in women with oncogene-driven lung cancer

Frequent surveillance imaging not linked to better outcomes following lung cancer surgery

Frequent surveillance imaging not linked to better outcomes following lung cancer surgery

Simultaneous radiation and immunotherapy can benefit mNSCLC patients with high tumor aneuploidy

Simultaneous radiation and immunotherapy can benefit mNSCLC patients with high tumor aneuploidy

Research findings could bolster the effectiveness of immune-checkpoint therapy

Research findings could bolster the effectiveness of immune-checkpoint therapy

New breakthrough could help spot lung cancer earlier and improve patient outcomes

New breakthrough could help spot lung cancer earlier and improve patient outcomes

Minorities with common form of lung cancer face longer wait times for receiving radiation therapy

Minorities with common form of lung cancer face longer wait times for receiving radiation therapy

Phase III ADAURA trial reveals promising results for patients with non-small cell lung cancer

Phase III ADAURA trial reveals promising results for patients with non-small cell lung cancer

Study identifies new therapeutic target against lung adenocarcinoma

Study identifies new therapeutic target against lung adenocarcinoma

Pollutant particles in the air trigger lung cancer in non-smokers

Pollutant particles in the air trigger lung cancer in non-smokers

Comprehensive genetic architecture atlas compiled for mutant RAS genes in cancers

Comprehensive genetic architecture atlas compiled for mutant RAS genes in cancers

CRISPR genome-editing technology can be used as a tool to discover RNA therapeutics for lung cancer

CRISPR genome-editing technology can be used as a tool to discover RNA therapeutics for lung cancer

First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLC

First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLC

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC